Business News Agency August 16 The pharmaceutical industry is expected to usher in a golden period of development. The world's best-selling drug, Lipitor, will lose patent protection in November this year. According to the Wall Street Journal in early August, Pfizer will introduce Lipitor, an over-the-counter (OTC) form, after the Lipitor patent expires, to reduce some of the economic losses.
According to a report released by IMS (Americas Market Research Corporation), the global pharmaceutical market in 2015 will reach 1.1 trillion US dollars. By that time, brand drugs with sales value of up to 160 billion US dollars will lose patent protection, and the global generic pharmaceutical industry will usher in a golden period of development.
It is understood that as of August 2013, there will be 15 drug patents expired, losing the "patent" of the protective shell, generic drug market competition will be more intense.
The drugs that expired on this patent include Lipitor, the lipid-lowering drug and the anticoagulant pill, which are the top two in terms of global sales. The reporter learned from the website of the State Food and Drug Administration that the only domestic manufacturer of Lipitor is Beijing Jialin Pharmaceutical Co., Ltd. Due to the expiration of patent protection, multinational pharmaceutical companies will face tremendous impact from generic drugs. In addition to high-priced original research drugs in China, multinational pharmaceutical companies have changed their tactics and have extended their reach into generic drugs and OTC fields.
According to a report released by IMS (Americas Market Research Corporation), the global pharmaceutical market in 2015 will reach 1.1 trillion US dollars. By that time, brand drugs with sales value of up to 160 billion US dollars will lose patent protection, and the global generic pharmaceutical industry will usher in a golden period of development.
It is understood that as of August 2013, there will be 15 drug patents expired, losing the "patent" of the protective shell, generic drug market competition will be more intense.
The drugs that expired on this patent include Lipitor, the lipid-lowering drug and the anticoagulant pill, which are the top two in terms of global sales. The reporter learned from the website of the State Food and Drug Administration that the only domestic manufacturer of Lipitor is Beijing Jialin Pharmaceutical Co., Ltd. Due to the expiration of patent protection, multinational pharmaceutical companies will face tremendous impact from generic drugs. In addition to high-priced original research drugs in China, multinational pharmaceutical companies have changed their tactics and have extended their reach into generic drugs and OTC fields.
We love transport chairs because they do just that. They are much lighter and more compact than traditional wheelchair and that is a game changer because you can take them just about anywhere.
Transit Aluminum Chair,much lighter and more compact than traditional wheelchair
jinan Fangqi Sunshine education consulting CO.,LTD. , https://www.fzrehabmarket.com